Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | ATRX |
| Upstream (Parents) |
|---|
| (<<) MPHOSPH8 → ATRX |
| (<<) RBM25 → ATRX |
| (<<) RIF1 → ATRX |
| Downstream (Children) |
|---|
| ATRX → CHD9 (>>) |
| ATRX → SGOL2 (>>) |
| ATRX → SAV1 (>>) |
| ATRX → RBM41 (>>) |
| ATRX → LYST (>>) |
| ATRX → ESF1 (>>) |
| ATRX → TRIM23 (>>) |
| ATRX → SECISBP2L (>>) |
| ATRX → CLK4 (>>) |
| ATRX → CEP110 (>>) |
| ATRX → SMCHD1 (>>) |
| ATRX → FLJ33630 (>>) |
| ATRX → MMAA (>>) |
| ATRX → ANKRD12 (>>) |
| ATRX → LMO7 (>>) |
| ATRX → MALAT1 (>>) |
| ATRX → RIF1 (>>) |
